The Moral Dilemma of Orphan Drug Prices

  Prescription drug prices are growing faster than ever, nowhere more so than in the market for orphan drugs, which are developed specifically to treat rare diseases. These medicines often cost more than $300,000 per patient per year, and a new generation of potentially curative gene therapies,…

The post The Moral Dilemma of Orphan Drug Prices appeared first on Funded Science.